Upregulation of endogenous ICAM-1 reduces ovarian cancer cell growth in the absence of immune cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of endogenous ICAM-1 reduces ovarian cancer cell growth in the absence of immune cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 2, Pages 280-290
Publisher
Wiley
Online
2013-07-06
DOI
10.1002/ijc.28375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors
- (2013) Christian Huisman et al. Molecular Oncology
- Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
- (2012) Sabine Stolzenburg et al. NUCLEIC ACIDS RESEARCH
- Epigenetic impact of dietary polyphenols in cancer chemoprevention: Lifelong remodeling of our epigenomes
- (2012) Wim Vanden Berghe PHARMACOLOGICAL RESEARCH
- Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer
- (2011) B T F van der Gun et al. BRITISH JOURNAL OF CANCER
- Reactivation ofMASPINin non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs)
- (2011) Adriana S. Beltran et al. Epigenetics
- Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer
- (2011) Christine Schröder et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ICAM-1: Getting a Grip on Leukocyte Adhesion
- (2011) E. O. Long JOURNAL OF IMMUNOLOGY
- StatBite Ovarian Cancer, Five-Year Stage-Specific Relative Survival Rates (2004-2008)
- (2011) JNCI-Journal of the National Cancer Institute
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell
- (2011) Wei Yu et al. PLoS One
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Aberrant Silencing of Cancer-Related Genes by CpG Hypermethylation Occurs Independently of Their Spatial Organization in the Nucleus
- (2010) H. P. Easwaran et al. CANCER RESEARCH
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis
- (2010) Xianzhen Hu et al. MOLECULAR IMMUNOLOGY
- Epigenetic Drugs Can Stimulate Metastasis through Enhanced Expression of the Pro-Metastatic Ezrin Gene
- (2010) Yanlin Yu et al. PLoS One
- Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women’s cancers
- (2010) Allison Jones et al. Epigenomics
- Zinc-finger-based artificial transcription factors and their applications
- (2009) Takashi Sera ADVANCED DRUG DELIVERY REVIEWS
- Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1
- (2009) Carina Strell et al. EXPERIMENTAL CELL RESEARCH
- Expression of intercellular adhesion molecule (ICAM)-1 in adenoid cystic carcinoma of the head and neck
- (2003) Akiko Shirai et al. LARYNGOSCOPE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started